For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit
Center for Research on End-of-Life Care

You are here


Found 45 results
Author Title Type [ Year(Asc)]
Filters: Author is Prigerson, Holly G  [Clear All Filters]
Trevino KM, Zhang B, Shen MJ, Prigerson HG.  2016.  Accuracy of Advanced Cancer Patients' Life Expectancy Estimates: The Role of Race and Source of Life Expectancy Information. Cancer.
Lambden J, Zhang B, Friedlander R, Prigerson HG.  2016.  Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.. J Palliat Med. 19(12):1296-1303.
Li J, Prigerson HG.  2016.  Assessment and associated features of prolonged grief disorder among Chinese bereaved individuals.. Compr Psychiatry. 66:9-16.
Garrido MM, Prigerson HG, Bao Y, Maciejewski PK.  2016.  Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life.. J Pain Symptom Manage. 51(5):875-881.e2.
Keating NL, Landrum MBeth, Huskamp HA, Kouri EM, Prigerson HG, Schrag D, Maciejewski PK, Hornbrook MC, Haggstrom DA.  2016.  Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients? Health Serv Res. 51(4):1584-94.
Roberts K, Holland J, Prigerson HG, Sweeney C, Corner G, Breitbart W, Lichtenthal WG.  2016.  Development of the Bereavement Risk Inventory and Screening Questionnaire (BRISQ): Item generation and expert panel feedback.. Palliat Support Care. :1-10.
Epstein AS, Prigerson HG, O'Reilly EM, Maciejewski PK.  2016.  Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer.. J Clin Oncol. 34(20):2398-403.
Weissman JS, Cooper Z, Hyder JA, Lipsitz S, Jiang W, Zinner MJ, Prigerson HG.  2016.  End-of-Life Care Intensity for Physicians, Lawyers, and the General Population.. JAMA. 315(3):303-5.
Prigerson HG, Neugut AI, Maciejewski PK.  2016.  Evaluating Chemotherapy at the End of Life--Reply.. JAMA Oncol. 2(1):144.
Trevino KM, Martin P, Prigerson HG.  2016.  Evaluating Quality Metrics for the Care of Patients With Blood Cancer Who Are Near Death.. J Clin Oncol.
Nissen KG, Trevino K, Lange T, Prigerson HG.  2016.  Family Relationships and Psychosocial Dysfunction among Family Caregivers of Patients with Advanced Cancer.. J Pain Symptom Manage.
Shen MJohnson, Prigerson HG, Paulk E, Trevino KM, Penedo FJ, Tergas AI, Epstein AS, Neugut AI, Maciejewski PK.  2016.  Impact of end-of-life discussions on the reduction of Latino/non-Latino disparities in do-not-resuscitate order completion.. Cancer.
Tsai W-I, Prigerson HG, Li C-Y, Chou W-C, Kuo S-C, Tang STzuh.  2016.  Longitudinal changes and predictors of prolonged grief for bereaved family caregivers over the first 2 years after the terminally ill cancer patient's death.. Palliat Med. 30(5):495-503.
Cea ME, M Reid C, Inturrisi C, Witkin LR, Prigerson HG, Bao Y.  2016.  Pain Assessment, Management, and Control Among Patients 65 Years or Older Receiving Hospice Care in the U.S.. J Pain Symptom Manage. 52(5):663-672.
Maciejewski PK, Maercker A, Boelen PA, Prigerson HG.  2016.  "Prolonged grief disorder" and "persistent complex bereavement disorder", but not "complicated grief", are one and the same diagnostic entity: an analysis of data from the Yale Bereavement Study.. World Psychiatry. 15(3):266-275.
Kentish-Barnes N, Prigerson HG.  2016.  Is this bereaved relative at risk of prolonged grief? Intensive Care Med. 42(8):1279-81.